580 reports of this reaction
2.3% of all CEFUROXIME reports
#6 most reported adverse reaction
RENAL FAILURE is the #6 most commonly reported adverse reaction for CEFUROXIME, manufactured by Hikma Pharmaceuticals USA Inc.. There are 580 FDA adverse event reports linking CEFUROXIME to RENAL FAILURE. This represents approximately 2.3% of all 25,003 adverse event reports for this drug.
Patients taking CEFUROXIME who experience renal failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RENAL FAILURE is a less commonly reported adverse event for CEFUROXIME, but still significant enough to appear in the safety profile.
In addition to renal failure, the following adverse reactions have been reported for CEFUROXIME:
The following drugs have also been linked to renal failure in FDA adverse event reports:
RENAL FAILURE has been reported as an adverse event in 580 FDA reports for CEFUROXIME. This does not prove causation, but indicates an association observed in post-market surveillance data.
RENAL FAILURE accounts for approximately 2.3% of all adverse event reports for CEFUROXIME, making it a notable side effect.
If you experience renal failure while taking CEFUROXIME, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.